A serious of reports have revealed the association between the XPG gene polymorphisms and tumor risk, including colorectal cancer [13], gastric cancer [14–16], lung cancer [17], head and neck cancer [18], and neuroblastoma [19]. The gene discussed is ERCC5; the disease is neoplasm.